Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV005090302 | SCV005834614 | pathogenic | not provided | 2024-11-17 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine, which is basic and polar, with tyrosine, which is neutral and polar, at codon 58 of the TOP2B protein (p.His58Tyr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with global developmental delay and intellectual disability (PMID: 28343847, 33644862). In at least one individual the variant was observed to be de novo. This variant is also known as c.187C>T (p.His63Tyr). ClinVar contains an entry for this variant (Variation ID: 265791). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects TOP2B function (PMID: 36450898). For these reasons, this variant has been classified as Pathogenic. |
Clinics for Rare Diseases Referral |
RCV000256202 | SCV000322735 | likely pathogenic | Autism spectrum disorder | 2016-10-11 | no assertion criteria provided | clinical testing |